Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Edoxaban pharmacokinetic study in cirrhosis with venous thromboembolism
NL-OMON49068Phase 4Completed
- Sponsor
- Tergooi MC
- Start
- Mar 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label trial of edoxaban in venous thromboembolism (VTE) (3 arms), sponsored by Tergooi MC. Primary endpoints: Edoxaban area under the plasma concentration curve, Maximum concentration and 2 more. Started Mar 2021; status: completed.
02
Drugs
edoxaban
03
Conditions
venous thromboembolism (VTE)
Beyond the preview
Go deeper on NL-OMON49068.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON49068.